Private Capital Group’s NanoViricides NNVC Stock Holding History

Private Capital Group’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400	Closed	-$2K	–	2167
2021 Q4	$2K	Hold	400	–	–	﹤0.01%	1813
2021 Q3	$2K	Hold	400	–	–	﹤0.01%	1871
2021 Q2	$2K	Hold	400	–	–	﹤0.01%	1861
2021 Q1	$2K	Hold	400	–	–	﹤0.01%	1775
2020 Q4	$1K	Hold	400	–	–	﹤0.01%	1925
2020 Q3	$2K	Hold	400	–	–	﹤0.01%	1723
2020 Q2	$3K	Hold	400	–	–	﹤0.01%	1617
2020 Q1	$2K	Buy	+400	New	+$2.83K	﹤0.01%	1686

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Private Capital Group's NNVC Position: Q1 2022 in Review

Private Capital Group sold out of NanoViricides (NNVC) in Q1 2022, closing a stake of 400 shares — an estimated $2K sold.

Private Capital Group first reported a position in NNVC in Q1 2020 and held it in 8 quarters. The position peaked at $3K in Q2 2020. 27 funds tracked by Wall St. Rank hold NNVC as of Q1 2022.

Private Capital Group reported no remaining NanoViricides position as of Q1 2022 after selling out during the quarter.
Private Capital Group sold 400 NanoViricides shares in Q1 2022, an estimated $2K.
Private Capital Group first reported a position in NanoViricides in Q1 2020 and held it in 8 quarters.
Private Capital Group's NanoViricides position peaked at $3K in Q2 2020.
27 funds tracked by Wall St. Rank held NanoViricides as of Q1 2022.

Based on Private Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.